Matches in Nanopublications for { ?s ?p "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP193425.RAtJfvAspfB2WUfbGLBu6pOgYMoEDSyUIugER1y-i6y-E130_assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP193425.RAtJfvAspfB2WUfbGLBu6pOgYMoEDSyUIugER1y-i6y-E130_provenance.
- NP429212.RAqDcoX5P3oaEQ2IBXTfmBTNi11Xg-iyxCrUuOODXhPK8130_assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429212.RAqDcoX5P3oaEQ2IBXTfmBTNi11Xg-iyxCrUuOODXhPK8130_provenance.
- NP335879.RA_59T8DvZf6soLS0OojWpUVFQWeR7yn-M9srkVP8NKgw130_assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335879.RA_59T8DvZf6soLS0OojWpUVFQWeR7yn-M9srkVP8NKgw130_provenance.
- assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP711738.RAeC4Ul3Ktik7pbx5-TpFjRsvTo4_iyP3TTqVTA1fE-hM130_assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711738.RAeC4Ul3Ktik7pbx5-TpFjRsvTo4_iyP3TTqVTA1fE-hM130_provenance.
- NP711740.RAWVhzSjDLBB4YV1wiah6G3-OT9fvqHCvihNHPT29X2V0130_assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711740.RAWVhzSjDLBB4YV1wiah6G3-OT9fvqHCvihNHPT29X2V0130_provenance.
- NP711737.RAM-CJMjyJ7HpdGQgvbEu3kFndFiLhS5YxatqiScERI-o130_assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711737.RAM-CJMjyJ7HpdGQgvbEu3kFndFiLhS5YxatqiScERI-o130_provenance.
- NP711733.RA4xBUNo6gi7nXWZrXF8DQxiwAPLyncY_YBDC70kft4Gw130_assertion description "[MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711733.RA4xBUNo6gi7nXWZrXF8DQxiwAPLyncY_YBDC70kft4Gw130_provenance.